Clinical Trial: Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654283) titled 'Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions' on May 28.

Brief Summary: This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).

Study Start Date: June 17

Study Type: INTERVENTIONAL

Condition: Hepatitis B, Chronic

Intervention: DRUG: AHB-137

Subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AusperBio Therapeutics Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....